 | • レポートコード：MRC2311L8437 • 出版社/出版日：LP Information / 2023年10月 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（2~3日） • 産業分類：化学＆材料 |
| Single User | ￥530,700 (USD3,660) | ▷ お問い合わせ |
| Corporate User | ￥1,061,400 (USD7,320) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| LPインフォメーションの最新刊調査レポート「世界の医療&製薬用活性炭市場」は、過去の販売実績から2022年の世界の医療&製薬用活性炭の総販売量を検討し、2023年から2029年の予測される医療&製薬用活性炭の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の医療&製薬用活性炭の市場規模を掲載し、XXX百万米ドル規模の世界の医療&製薬用活性炭市場の詳細な分析を提供します。本インサイトレポートは、世界の医療&製薬用活性炭業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。 また、本レポートでは、加速する世界の医療&製薬用活性炭市場における各社の独自のポジションをより深く理解するために、医療&製薬用活性炭製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。 世界の医療&製薬用活性炭市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。医療&製薬用活性炭の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。医療&製薬用活性炭の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。医療&製薬用活性炭のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。 医療&製薬用活性炭の世界主要メーカーとしては、Kuraray、 Osaka Gas Chemicals、 YL、 CABOT、 Ingevity、 Haycarb、 JD、 Shenhua Group、 ADA-ES、 Fujian Xinsen Carbon、 MULINSEN ACTIVATED CARBON、 Shanxi XinHua Chemical、 Boyce Carbon、 DESOTEC Activated Carbon、 HuaHui-Carbon、 ZHI XING、 Silcarbon Aktivkohle GmbH、 Jiangsu Zhuxi Activated Carbon、 Inner Mongolia TaiXi Coal Group、 Active Char Productsなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。 本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の医療&製薬用活性炭市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。 【市場細分化】 この調査では医療&製薬用活性炭市場をセグメンテーションし、種類別 (粉末活性炭、粒状活性炭、その他)、用途別 (医療、医薬品)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。 ・種類別区分：粉末活性炭、粒状活性炭、その他 ・用途別区分：医療、医薬品 ・地域別区分 南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル） アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア） ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア） 中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国） 【本レポートで扱う主な質問】 ・世界の医療&製薬用活性炭市場の10年間の市場状況・展望は？ ・世界および地域別に見た医療&製薬用活性炭市場成長の要因は何か？ ・医療&製薬用活性炭の市場機会はエンドマーケットの規模によってどのように変化するのか？ ・医療&製薬用活性炭のタイプ別、用途別の内訳は？ ・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？ ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要：医療&製薬用活性炭の年間販売量2018-2029、地域別現状・将来分析 ・医療&製薬用活性炭の種類別セグメント：粉末活性炭、粒状活性炭、その他 ・医療&製薬用活性炭の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格 ・医療&製薬用活性炭の用途別セグメント：医療、医薬品 ・医療&製薬用活性炭の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格 企業別世界の医療&製薬用活性炭市場 ・企業別のグローバル医療&製薬用活性炭市場データ：2018-2023年の年間販売量、市場シェア ・企業別の医療&製薬用活性炭の年間売上：2018-2023年の売上、市場シェア ・企業別の医療&製薬用活性炭販売価格 ・主要企業の医療&製薬用活性炭生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 医療&製薬用活性炭の地域別レビュー ・地域別の医療&製薬用活性炭市場規模2018-2023：年間販売量、売上 ・主要国別の医療&製薬用活性炭市場規模2018-2023：年間販売量、売上 ・南北アメリカの医療&製薬用活性炭販売の成長 ・アジア太平洋の医療&製薬用活性炭販売の成長 ・ヨーロッパの医療&製薬用活性炭販売の成長 ・中東・アフリカの医療&製薬用活性炭販売の成長 南北アメリカ市場 ・南北アメリカの国別の医療&製薬用活性炭販売量、売上（2018-2023） ・南北アメリカの医療&製薬用活性炭の種類別販売量 ・南北アメリカの医療&製薬用活性炭の用途別販売量 ・アメリカ市場 ・カナダ市場 ・メキシコ市場 ・ブラジル市場 アジア太平洋市場 ・アジア太平洋の国別の医療&製薬用活性炭販売量、売上（2018-2023） ・アジア太平洋の医療&製薬用活性炭の種類別販売量 ・アジア太平洋の医療&製薬用活性炭の用途別販売量 ・中国市場 ・日本市場 ・韓国市場 ・東南アジア市場 ・インド市場 ・オーストラリア市場 ・台湾市場 ヨーロッパ市場 ・ヨーロッパの国別の医療&製薬用活性炭販売量、売上（2018-2023） ・ヨーロッパの医療&製薬用活性炭の種類別販売量 ・ヨーロッパの医療&製薬用活性炭の用途別販売量 ・ドイツ市場 ・フランス市場 ・イギリス市場 ・イタリア市場 ・ロシア市場 中東・アフリカ市場 ・中東・アフリカの国別の医療&製薬用活性炭販売量、売上（2018-2023） ・中東・アフリカの医療&製薬用活性炭の種類別販売量 ・中東・アフリカの医療&製薬用活性炭の用途別販売量 ・エジプト市場 ・南アフリカ市場 ・イスラエル市場 ・トルコ市場 ・GCC諸国市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・医療&製薬用活性炭の製造コスト構造分析 ・医療&製薬用活性炭の製造プロセス分析 ・医療&製薬用活性炭の産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル：直接販売チャンネル、間接販売チャンネル ・医療&製薬用活性炭の主要なグローバル販売業者 ・医療&製薬用活性炭の主要なグローバル顧客 地域別の医療&製薬用活性炭市場予測レビュー ・地域別の医療&製薬用活性炭市場規模予測（2024-2029） ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・ヨーロッパの国別予測 ・医療&製薬用活性炭の種類別市場規模予測 ・医療&製薬用活性炭の用途別市場規模予測 主要企業分析 Kuraray、 Osaka Gas Chemicals、 YL、 CABOT、 Ingevity、 Haycarb、 JD、 Shenhua Group、 ADA-ES、 Fujian Xinsen Carbon、 MULINSEN ACTIVATED CARBON、 Shanxi XinHua Chemical、 Boyce Carbon、 DESOTEC Activated Carbon、 HuaHui-Carbon、 ZHI XING、 Silcarbon Aktivkohle GmbH、 Jiangsu Zhuxi Activated Carbon、 Inner Mongolia TaiXi Coal Group、 Active Char Products ・企業情報 ・医療&製薬用活性炭製品 ・医療&製薬用活性炭販売量、売上、価格、粗利益（2018-2023） ・主要ビジネス概要 ・最新動向 調査結果および結論 |
The global Medical & Pharmaceutical Grade Activated Carbon market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Medical & Pharmaceutical Grade Activated Carbon is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Medical & Pharmaceutical Grade Activated Carbon is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Medical & Pharmaceutical Grade Activated Carbon is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Medical & Pharmaceutical Grade Activated Carbon players cover Kuraray, Osaka Gas Chemicals, YL, CABOT, Ingevity, Haycarb, JD, Shenhua Group and ADA-ES, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Activated carbon, also called activated charcoal, is a form of carbon commonly used to filter contaminants from water and air, among many other uses. It is processed to have small, low-volume pores that increase the surface area available for adsorption or chemical reactions.
LPI (LP Information)’ newest research report, the “Medical & Pharmaceutical Grade Activated Carbon Industry Forecast” looks at past sales and reviews total world Medical & Pharmaceutical Grade Activated Carbon sales in 2022, providing a comprehensive analysis by region and market sector of projected Medical & Pharmaceutical Grade Activated Carbon sales for 2023 through 2029. With Medical & Pharmaceutical Grade Activated Carbon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical & Pharmaceutical Grade Activated Carbon industry.
This Insight Report provides a comprehensive analysis of the global Medical & Pharmaceutical Gr……
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical & Pharmaceutical Grade Activated Carbon Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Medical & Pharmaceutical Grade Activated Carbon by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Medical & Pharmaceutical Grade Activated Carbon by Country/Region, 2018, 2022 & 2029
2.2 Medical & Pharmaceutical Grade Activated Carbon Segment by Type
2.2.1 Powder Activated Carbon
2.2.2 Granular Activated Carbon
2.2.3 Others
2.3 Medical & Pharmaceutical Grade Activated Carbon Sales by Type
2.3.1 Global Medical & Pharmaceutical Grade Activated Carbon Sales Market Share by Type (2018-2023)
2.3.2 Global Medical & Pharmaceutical Grade Activated Carbon Revenue and Market Share by Type (2018-2023)
2.3.3 Global Medical & Pharmaceutical Grade Activated Carbon Sale Price by Type (2018-2023)
2.4 Medical & Pharmaceutical Grade Activated Carbon Segment by Application
2.4.1 Medical
2.4.2 Pharmaceutical
2.5 Medical & Pharmaceutical Grade Activated Carbon Sales by Application
2.5.1 Global Medical & Pharmaceutical Grade Activated Carbon Sale Market Share by Application (2018-2023)
2.5.2 Global Medical & Pharmaceutical Grade Activated Carbon Revenue and Market Share by Application (2018-2023)
2.5.3 Global Medical & Pharmaceutical Grade Activated Carbon Sale Price by Application (2018-2023)
3 Global Medical & Pharmaceutical Grade Activated Carbon by Company
3.1 Global Medical & Pharmaceutical Grade Activated Carbon Breakdown Data by Company
3.1.1 Global Medical & Pharmaceutical Grade Activated Carbon Annual Sales by Company (2018-2023)
3.1.2 Global Medical & Pharmaceutical Grade Activated Carbon Sales Market Share by Company (2018-2023)
3.2 Global Medical & Pharmaceutical Grade Activated Carbon Annual Revenue by Company (2018-2023)
3.2.1 Global Medical & Pharmaceutical Grade Activated Carbon Revenue by Company (2018-2023)
3.2.2 Global Medical & Pharmaceutical Grade Activated Carbon Revenue Market Share by Company (2018-2023)
3.3 Global Medical & Pharmaceutical Grade Activated Carbon Sale Price by Company
3.4 Key Manufacturers Medical & Pharmaceutical Grade Activated Carbon Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical & Pharmaceutical Grade Activated Carbon Product Location Distribution
3.4.2 Players Medical & Pharmaceutical Grade Activated Carbon Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Medical & Pharmaceutical Grade Activated Carbon by Geographic Region
4.1 World Historic Medical & Pharmaceutical Grade Activated Carbon Market Size by Geographic Region (2018-2023)
4.1.1 Global Medical & Pharmaceutical Grade Activated Carbon Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Medical & Pharmaceutical Grade Activated Carbon Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Medical & Pharmaceutical Grade Activated Carbon Market Size by Country/Region (2018-2023)
4.2.1 Global Medical & Pharmaceutical Grade Activated Carbon Annual Sales by Country/Region (2018-2023)
4.2.2 Global Medical & Pharmaceutical Grade Activated Carbon Annual Revenue by Country/Region (2018-2023)
4.3 Americas Medical & Pharmaceutical Grade Activated Carbon Sales Growth
4.4 APAC Medical & Pharmaceutical Grade Activated Carbon Sales Growth
4.5 Europe Medical & Pharmaceutical Grade Activated Carbon Sales Growth
4.6 Middle East & Africa Medical & Pharmaceutical Grade Activated Carbon Sales Growth
5 Americas
5.1 Americas Medical & Pharmaceutical Grade Activated Carbon Sales by Country
5.1.1 Americas Medical & Pharmaceutical Grade Activated Carbon Sales by Country (2018-2023)
5.1.2 Americas Medical & Pharmaceutical Grade Activated Carbon Revenue by Country (2018-2023)
5.2 Americas Medical & Pharmaceutical Grade Activated Carbon Sales by Type
5.3 Americas Medical & Pharmaceutical Grade Activated Carbon Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical & Pharmaceutical Grade Activated Carbon Sales by Region
6.1.1 APAC Medical & Pharmaceutical Grade Activated Carbon Sales by Region (2018-2023)
6.1.2 APAC Medical & Pharmaceutical Grade Activated Carbon Revenue by Region (2018-2023)
6.2 APAC Medical & Pharmaceutical Grade Activated Carbon Sales by Type
6.3 APAC Medical & Pharmaceutical Grade Activated Carbon Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Medical & Pharmaceutical Grade Activated Carbon by Country
7.1.1 Europe Medical & Pharmaceutical Grade Activated Carbon Sales by Country (2018-2023)
7.1.2 Europe Medical & Pharmaceutical Grade Activated Carbon Revenue by Country (2018-2023)
7.2 Europe Medical & Pharmaceutical Grade Activated Carbon Sales by Type
7.3 Europe Medical & Pharmaceutical Grade Activated Carbon Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical & Pharmaceutical Grade Activated Carbon by Country
8.1.1 Middle East & Africa Medical & Pharmaceutical Grade Activated Carbon Sales by Country (2018-2023)
8.1.2 Middle East & Africa Medical & Pharmaceutical Grade Activated Carbon Revenue by Country (2018-2023)
8.2 Middle East & Africa Medical & Pharmaceutical Grade Activated Carbon Sales by Type
8.3 Middle East & Africa Medical & Pharmaceutical Grade Activated Carbon Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical & Pharmaceutical Grade Activated Carbon
10.3 Manufacturing Process Analysis of Medical & Pharmaceutical Grade Activated Carbon
10.4 Industry Chain Structure of Medical & Pharmaceutical Grade Activated Carbon
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical & Pharmaceutical Grade Activated Carbon Distributors
11.3 Medical & Pharmaceutical Grade Activated Carbon Customer
12 World Forecast Review for Medical & Pharmaceutical Grade Activated Carbon by Geographic Region
12.1 Global Medical & Pharmaceutical Grade Activated Carbon Market Size Forecast by Region
12.1.1 Global Medical & Pharmaceutical Grade Activated Carbon Forecast by Region (2024-2029)
12.1.2 Global Medical & Pharmaceutical Grade Activated Carbon Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Medical & Pharmaceutical Grade Activated Carbon Forecast by Type
12.7 Global Medical & Pharmaceutical Grade Activated Carbon Forecast by Application
13 Key Players Analysis
13.1 Kuraray
13.1.1 Kuraray Company Information
13.1.2 Kuraray Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.1.3 Kuraray Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Kuraray Main Business Overview
13.1.5 Kuraray Latest Developments
13.2 Osaka Gas Chemicals
13.2.1 Osaka Gas Chemicals Company Information
13.2.2 Osaka Gas Chemicals Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.2.3 Osaka Gas Chemicals Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Osaka Gas Chemicals Main Business Overview
13.2.5 Osaka Gas Chemicals Latest Developments
13.3 YL
13.3.1 YL Company Information
13.3.2 YL Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.3.3 YL Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 YL Main Business Overview
13.3.5 YL Latest Developments
13.4 CABOT
13.4.1 CABOT Company Information
13.4.2 CABOT Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.4.3 CABOT Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 CABOT Main Business Overview
13.4.5 CABOT Latest Developments
13.5 Ingevity
13.5.1 Ingevity Company Information
13.5.2 Ingevity Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.5.3 Ingevity Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Ingevity Main Business Overview
13.5.5 Ingevity Latest Developments
13.6 Haycarb
13.6.1 Haycarb Company Information
13.6.2 Haycarb Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.6.3 Haycarb Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Haycarb Main Business Overview
13.6.5 Haycarb Latest Developments
13.7 JD
13.7.1 JD Company Information
13.7.2 JD Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.7.3 JD Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 JD Main Business Overview
13.7.5 JD Latest Developments
13.8 Shenhua Group
13.8.1 Shenhua Group Company Information
13.8.2 Shenhua Group Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.8.3 Shenhua Group Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Shenhua Group Main Business Overview
13.8.5 Shenhua Group Latest Developments
13.9 ADA-ES
13.9.1 ADA-ES Company Information
13.9.2 ADA-ES Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.9.3 ADA-ES Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 ADA-ES Main Business Overview
13.9.5 ADA-ES Latest Developments
13.10 Fujian Xinsen Carbon
13.10.1 Fujian Xinsen Carbon Company Information
13.10.2 Fujian Xinsen Carbon Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.10.3 Fujian Xinsen Carbon Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Fujian Xinsen Carbon Main Business Overview
13.10.5 Fujian Xinsen Carbon Latest Developments
13.11 MULINSEN ACTIVATED CARBON
13.11.1 MULINSEN ACTIVATED CARBON Company Information
13.11.2 MULINSEN ACTIVATED CARBON Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.11.3 MULINSEN ACTIVATED CARBON Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 MULINSEN ACTIVATED CARBON Main Business Overview
13.11.5 MULINSEN ACTIVATED CARBON Latest Developments
13.12 Shanxi XinHua Chemical
13.12.1 Shanxi XinHua Chemical Company Information
13.12.2 Shanxi XinHua Chemical Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.12.3 Shanxi XinHua Chemical Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Shanxi XinHua Chemical Main Business Overview
13.12.5 Shanxi XinHua Chemical Latest Developments
13.13 Boyce Carbon
13.13.1 Boyce Carbon Company Information
13.13.2 Boyce Carbon Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.13.3 Boyce Carbon Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Boyce Carbon Main Business Overview
13.13.5 Boyce Carbon Latest Developments
13.14 DESOTEC Activated Carbon
13.14.1 DESOTEC Activated Carbon Company Information
13.14.2 DESOTEC Activated Carbon Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.14.3 DESOTEC Activated Carbon Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 DESOTEC Activated Carbon Main Business Overview
13.14.5 DESOTEC Activated Carbon Latest Developments
13.15 HuaHui-Carbon
13.15.1 HuaHui-Carbon Company Information
13.15.2 HuaHui-Carbon Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.15.3 HuaHui-Carbon Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 HuaHui-Carbon Main Business Overview
13.15.5 HuaHui-Carbon Latest Developments
13.16 ZHI XING
13.16.1 ZHI XING Company Information
13.16.2 ZHI XING Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.16.3 ZHI XING Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 ZHI XING Main Business Overview
13.16.5 ZHI XING Latest Developments
13.17 Silcarbon Aktivkohle GmbH
13.17.1 Silcarbon Aktivkohle GmbH Company Information
13.17.2 Silcarbon Aktivkohle GmbH Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.17.3 Silcarbon Aktivkohle GmbH Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Silcarbon Aktivkohle GmbH Main Business Overview
13.17.5 Silcarbon Aktivkohle GmbH Latest Developments
13.18 Jiangsu Zhuxi Activated Carbon
13.18.1 Jiangsu Zhuxi Activated Carbon Company Information
13.18.2 Jiangsu Zhuxi Activated Carbon Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.18.3 Jiangsu Zhuxi Activated Carbon Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Jiangsu Zhuxi Activated Carbon Main Business Overview
13.18.5 Jiangsu Zhuxi Activated Carbon Latest Developments
13.19 Inner Mongolia TaiXi Coal Group
13.19.1 Inner Mongolia TaiXi Coal Group Company Information
13.19.2 Inner Mongolia TaiXi Coal Group Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.19.3 Inner Mongolia TaiXi Coal Group Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Inner Mongolia TaiXi Coal Group Main Business Overview
13.19.5 Inner Mongolia TaiXi Coal Group Latest Developments
13.20 Active Char Products
13.20.1 Active Char Products Company Information
13.20.2 Active Char Products Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.20.3 Active Char Products Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Active Char Products Main Business Overview
13.20.5 Active Char Products Latest Developments
14 Research Findings and Conclusion